The CyberKnife Center of Chicago is located in Elmhurst, Illinois and is a service of Elmhurst Memorial Hospital. It uses the CyberKnife system to perform stereotactic radiosurgery, a noninvasive procedure, to treat tumors. The CyberKnife system is a robotic linear accelerator that moves around the patient and fires radiation beams from numerous angles to treat tumors while minimizing radiation exposure to healthy tissue.
Illinois CyberKnife is a department of Advocate Lutheran General Hospital that provides stereotactic radiosurgery using the CyberKnife system. The CyberKnife is a robotic radiosurgery system that treats tumors noninvasively using high doses of radiation targeted precisely from multiple angles. Treatments are painless, require no anesthesia, and take 30-90 minutes to complete while continuously tracking and correcting for tumor or patient movement.
Columbus CyberKnife provides stereotactic radiosurgery using the CyberKnife system. It is a non-invasive treatment that delivers high doses of radiation to tumors from multiple angles using a robotic arm. Treatments are painless and take 30-90 minutes to complete, often requiring only 1-5 sessions to treat conditions like brain tumors, lung tumors, and more. Columbus CyberKnife is part of the US Radiosurgery network and affiliated with Mount Carmel St. Ann's Hospital.
The document provides information about Austin CyberKnife and the CyberKnife treatment process. [1] Austin CyberKnife is a department of University Medical Center Brackenridge that uses the CyberKnife system to perform stereotactic radiosurgery, a noninvasive method of treating tumors with high-dose radiation from multiple angles. [2] The CyberKnife system works using a compact linear accelerator attached to a robotic arm to move around the patient and fire radiation beams from many angles, continuously tracking and compensating for tumor or patient movement. [3] The treatment process involves imaging scans, developing a customized treatment plan, and one to five outpatient sessions where the robotic arm delivers radiation beams while tracking movements.
Louisville CyberKnife is a radiosurgery service located at the James Graham Brown Cancer Center in Louisville, Kentucky. It uses the CyberKnife system to precisely deliver high doses of radiation to tumors using a robotic arm. Treatments are non-invasive, painless, and take 30-90 minutes to complete over 3-5 sessions. The center is part of a national network and works with experienced physicians to provide exceptional care for cancer patients.
1) The document discusses perspectives on image-guided radiation therapy (IGRT) from physicians and physicists at the University of California San Diego (UCSD).
2) UCSD has implemented IGRT using both planar kV imaging and volumetric cone-beam CT (CBCT) primarily for prostate and gynecological cancers.
3) IGRT provides benefits of improved target localization and the potential for treatment adaptation if tumor size changes over the course of treatment are detected. However, proper quality assurance is needed when implementing an IGRT program.
Dose Escalation By Imrt And Organ Trackingin Prostate Cancerfondas vakalis
1) This study assessed toxicity in 18 patients treated with dose-escalated IMRT to 80 Gy for prostate cancer while using organ tracking of the prostate.
2) Acute and early late toxicity was minimal, with limited urinary toxicity and minimal rectal toxicity observed.
3) Dose volume histograms showed dose constraints for organs at risk were met.
4) Further follow-up is still needed to fully assess long-term toxicity and efficacy of this aggressive dose escalation approach.
Adaptive Radiation Therapy With Tomo Therapyfondas vakalis
The document discusses TomoTherapy's implementation of image-guided adaptive radiation therapy which uses megavoltage CT (MVCT) imaging for patient alignment and deformable image registration between MVCT and diagnostic kVCT images to automatically evaluate changes in patient anatomy and recalculate dose distributions on a daily basis to facilitate adaptive replanning when needed.
This document discusses prostate motion and its impact on image-guided radiotherapy for prostate cancer. It finds that the rectum is a major source of interfractional prostate variation. Strategies like rectal emptying can help reduce shifts. Daily imaging allows for reduced planning target volume margins and decreased rectal toxicity despite dose escalation. However, optimal clinical target volume to planning target volume expansions remain unclear due to factors like extracapsular extension and residual errors. Different image guidance methods each have benefits and limitations for margin reduction and dose escalation in prostate cancer radiotherapy.
Illinois CyberKnife is a department of Advocate Lutheran General Hospital that provides stereotactic radiosurgery using the CyberKnife system. The CyberKnife is a robotic radiosurgery system that treats tumors noninvasively using high doses of radiation targeted precisely from multiple angles. Treatments are painless, require no anesthesia, and take 30-90 minutes to complete while continuously tracking and correcting for tumor or patient movement.
Columbus CyberKnife provides stereotactic radiosurgery using the CyberKnife system. It is a non-invasive treatment that delivers high doses of radiation to tumors from multiple angles using a robotic arm. Treatments are painless and take 30-90 minutes to complete, often requiring only 1-5 sessions to treat conditions like brain tumors, lung tumors, and more. Columbus CyberKnife is part of the US Radiosurgery network and affiliated with Mount Carmel St. Ann's Hospital.
The document provides information about Austin CyberKnife and the CyberKnife treatment process. [1] Austin CyberKnife is a department of University Medical Center Brackenridge that uses the CyberKnife system to perform stereotactic radiosurgery, a noninvasive method of treating tumors with high-dose radiation from multiple angles. [2] The CyberKnife system works using a compact linear accelerator attached to a robotic arm to move around the patient and fire radiation beams from many angles, continuously tracking and compensating for tumor or patient movement. [3] The treatment process involves imaging scans, developing a customized treatment plan, and one to five outpatient sessions where the robotic arm delivers radiation beams while tracking movements.
Louisville CyberKnife is a radiosurgery service located at the James Graham Brown Cancer Center in Louisville, Kentucky. It uses the CyberKnife system to precisely deliver high doses of radiation to tumors using a robotic arm. Treatments are non-invasive, painless, and take 30-90 minutes to complete over 3-5 sessions. The center is part of a national network and works with experienced physicians to provide exceptional care for cancer patients.
1) The document discusses perspectives on image-guided radiation therapy (IGRT) from physicians and physicists at the University of California San Diego (UCSD).
2) UCSD has implemented IGRT using both planar kV imaging and volumetric cone-beam CT (CBCT) primarily for prostate and gynecological cancers.
3) IGRT provides benefits of improved target localization and the potential for treatment adaptation if tumor size changes over the course of treatment are detected. However, proper quality assurance is needed when implementing an IGRT program.
Dose Escalation By Imrt And Organ Trackingin Prostate Cancerfondas vakalis
1) This study assessed toxicity in 18 patients treated with dose-escalated IMRT to 80 Gy for prostate cancer while using organ tracking of the prostate.
2) Acute and early late toxicity was minimal, with limited urinary toxicity and minimal rectal toxicity observed.
3) Dose volume histograms showed dose constraints for organs at risk were met.
4) Further follow-up is still needed to fully assess long-term toxicity and efficacy of this aggressive dose escalation approach.
Adaptive Radiation Therapy With Tomo Therapyfondas vakalis
The document discusses TomoTherapy's implementation of image-guided adaptive radiation therapy which uses megavoltage CT (MVCT) imaging for patient alignment and deformable image registration between MVCT and diagnostic kVCT images to automatically evaluate changes in patient anatomy and recalculate dose distributions on a daily basis to facilitate adaptive replanning when needed.
This document discusses prostate motion and its impact on image-guided radiotherapy for prostate cancer. It finds that the rectum is a major source of interfractional prostate variation. Strategies like rectal emptying can help reduce shifts. Daily imaging allows for reduced planning target volume margins and decreased rectal toxicity despite dose escalation. However, optimal clinical target volume to planning target volume expansions remain unclear due to factors like extracapsular extension and residual errors. Different image guidance methods each have benefits and limitations for margin reduction and dose escalation in prostate cancer radiotherapy.
Oklahoma CyberKnife treats several different types of malignant and benign tumors in the brain, spine, lung, liver, pancreas, prostate, kidney and eye. Lung tumors, brain tumors and prostate cancer are some of the center’s most frequently treated diseases. Oklahoma CyberKnife also has specialized expertise in the treatment of trigeminal neuralgia, a neuropathic disorder that causes intense pain in the face, forehead and jaw.
4D-IGRT involves accounting for tumor motion during radiation therapy delivery. It uses 4D computed tomography (4D CT) imaging, which captures tumor position at different respiratory phases. This allows delineation of an internal target volume (ITV) that encompasses the full range of tumor motion. Treatment can then be delivered over the entire respiratory cycle or gated to a specific phase such as end-exhalation using respiratory tracking systems. The goal is to ensure accurate radiation delivery while minimizing doses to surrounding healthy tissues.
Identified in 1921 by James Ewing
2nd most common bone tumor in children
Ewing’s Sarcoma Family of tumors:
Ewing’s sarcoma (Bone –87%)
Extraosseous Ewing’s sarcoma (8%)
Peripheral PNET(5%)
Askin’s tumor
Reno CyberKnife is a radiosurgery service located in Reno, Nevada that uses the CyberKnife system to precisely deliver high doses of radiation to tumors with minimal damage to surrounding tissue. The CyberKnife system is robotic and its arm can deliver radiation beams from many angles while continuously tracking and compensating for tumor or patient movement throughout the treatment. CyberKnife treatments typically require just one to five visits and have minimal side effects compared to conventional radiation therapy.
The CyberKnife is a frameless robotic radiosurgery system used to treat both benign and malignant tumors. It was invented in the 1990s and is manufactured by Accuray. It uses a compact linear accelerator mounted on a robotic arm to deliver radiation from many angles and can track tumor motion using X-ray imaging and respiratory tracking sensors. Treatment planning involves defining target volumes and constructing a correspondence model between internal fiducial markers and external sensors to track tumor position in real-time during delivery. The CyberKnife provides an alternative to frame-based radiosurgery and can fractionate treatment over multiple days.
8% of all bone tumors present in spine
25-30% of bone tumors are benign
Peak age: 2-3rd decade
Posterior element involved: osteoid osteoma, osteoblastoma, aneurysmal bone cyst
Anterior element involved: giant cell tumor, hemangioma, eosinophilic granuloma
This document summarizes key points about spinal metastasis including epidemiology, symptoms, diagnostic imaging, and treatment approaches. Spinal metastasis most commonly affects the thoracic spine and presents as back pain in 70-95% of patients. Imaging plays an important role in diagnosis, with MRI and CT being most sensitive and specific. Treatment depends on factors such as neurological involvement, tumor type, and mechanical stability, and may include radiation, surgery, chemotherapy, or bisphosphonates. The goal of treatment is pain relief and preservation of neurological function.
Benign bone tumors are diverse in morphology and biological potential. Most bone tumors are benign lesions seen in patients under 30 years old. Radiology is important for determining the exact location, extent of growth, and aggressiveness of bone tumors. The best test for diagnosis is a biopsy, as it confirms if a tumor is malignant or benign and determines the bone cancer type and stage. There are several classification systems for bone tumors, including the Enneking and Campanacci staging systems, which help determine prognosis and appropriate treatment.
A new software has been developed to measure the hip-knee condylar angle using digital radiological images and computer analysis. In a study comparing the new computerized method to conventional manual goniometry, 60 knee x-rays following total knee arthroplasty were measured twice by the same observer using both methods. Statistical analysis showed the computerized method produced highly reproducible results with a mean difference of 0.324 degrees between readings and a Pearson correlation of 0.999. The new software allows for precise, reliable and inexpensive measurement of joint angles that can be performed by non-medical personnel.
Presacral tumors are rare lesions located in the retrorectal space. They can be congenital, neurogenic, osseous, or other types. MRI is the best imaging modality to evaluate these tumors. Surgical resection is usually required given the risk of malignancy. The surgical approach depends on the location and extent of the tumor, and may involve the abdomen, perineum, or a combined approach. Complete resection with negative margins while preserving function is the goal.
Cyberknife is a robotic radiosurgery system that can treat tumors anywhere in the body with sub-millimeter accuracy. It contains a linear accelerator mounted on a robotic arm that moves in six degrees of freedom to accurately deliver radiation from numerous angles. Treatment is tracked in real-time using x-ray images and the robotic arm moves to correct for any tumor motion during treatment. Cyberknife allows for both single and multiple fraction stereotactic radiosurgery treatments without the need for invasive head frames.
This document discusses sarcomas from a surgical perspective. It defines sarcomas as heterogeneous tumors originating from mesoderm or ectoderm. The most common sarcoma subtypes are pleomorphic sarcoma, gastrointestinal stromal tumor, liposarcoma, and leiomyosarcoma. Sarcomas most often occur in extremities, trunk, and retroperitoneum. Diagnosis involves imaging like MRI or CT along with biopsy. Treatment typically involves surgical resection with negative margins, with chemotherapy or radiation used adjuvantly depending on risk factors. Prognosis depends on factors like size, grade, and margin status.
Ewing sarcoma and osteosarcoma are two of the most common primary bone cancers in children and adolescents. Ewing sarcoma accounts for about 2% of childhood cancers and most often affects bones of the pelvis, femur, and ribs in the second decade of life. The most frequent genetic abnormality in Ewing sarcoma is a translocation between chromosomes 11 and 22. Osteosarcoma is the most common primary bone tumor in children and makes up about 4% of childhood cancers, typically affecting the distal femur, proximal tibia, and proximal humerus. Both cancers commonly present with pain and swelling and can metastasize to the lungs. Treatment involves chemotherapy, surgery, and sometimes radiation.
The Cytotron 864 is a new non-invasive device developed by Scalene Cybernetics for tissue regeneration and repair of chronic diseases like cancer and arthritis. It works by delivering precise doses of radiofrequency beams in the presence of magnetic fields to alter cell membrane potentials and control cell division, thereby stimulating tissue regeneration or stopping tumor growth. The technology was developed by Dr. Rajah Vijay Kumar and his team at the Center for Advanced Research and Development, and clinical studies show it is effective in treating conditions like osteoarthritis and certain types of cancer in a painless manner without side effects.
The parapharyngeal space is a potential space located in the neck that contains important structures like the carotid artery and cranial nerves. Tumors in this space can be benign or malignant, with the most common types being salivary gland tumors in the prestyloid space and neurogenic tumors in the retrostyloid space. Imaging like CT and MRI are used to determine the location and characteristics of the tumor. Surgical excision is typically the primary treatment, with the surgical approach depending on factors like size and involvement of surrounding structures. Observation or radiation therapy may be options for certain patients who cannot undergo surgery.
At our Cancer Care Center in Beloit, Wisconsin we have the most technologically advanced levels of Cancer Surgery. Call our Cancer Care Center at 608-364-5253
Ewing's sarcoma is a rare cancer that affects bones or soft tissue. It is characterized by small, round cancer cells and commonly affects children and young adults. Treatment involves induction chemotherapy, followed by local therapy with surgery or radiation if possible, along with additional maintenance chemotherapy. The multimodal approach has improved survival rates in recent decades, though long-term outcomes remain challenging due to the risk of recurrence or secondary cancers.
The National Comprehensive Cancer Network updated its NCNN Clinical Practice Guidelines in Oncology® to include stereotactic body radiation therapy as a treatment option for prostate cancer. CyberKnife Center of Chicago specializes in stereotactic radiosurgery and stereotactic body radiation therapy using CyberKnife® technology. If you are interested in learning more about CyberKnife Center of Chicago, call 331-221-2050 to speak with a representative.
CyberKnife Center of Chicago presents the American Cancer Society Facts and Figures 2014 annual report outlining the estimated numbers of new cancer cases and deaths in 2014 as well as current cancer incidence, mortality, and survival statistics and information on cancer symptoms, risk factors, early detection and treatment.
Oklahoma CyberKnife treats several different types of malignant and benign tumors in the brain, spine, lung, liver, pancreas, prostate, kidney and eye. Lung tumors, brain tumors and prostate cancer are some of the center’s most frequently treated diseases. Oklahoma CyberKnife also has specialized expertise in the treatment of trigeminal neuralgia, a neuropathic disorder that causes intense pain in the face, forehead and jaw.
4D-IGRT involves accounting for tumor motion during radiation therapy delivery. It uses 4D computed tomography (4D CT) imaging, which captures tumor position at different respiratory phases. This allows delineation of an internal target volume (ITV) that encompasses the full range of tumor motion. Treatment can then be delivered over the entire respiratory cycle or gated to a specific phase such as end-exhalation using respiratory tracking systems. The goal is to ensure accurate radiation delivery while minimizing doses to surrounding healthy tissues.
Identified in 1921 by James Ewing
2nd most common bone tumor in children
Ewing’s Sarcoma Family of tumors:
Ewing’s sarcoma (Bone –87%)
Extraosseous Ewing’s sarcoma (8%)
Peripheral PNET(5%)
Askin’s tumor
Reno CyberKnife is a radiosurgery service located in Reno, Nevada that uses the CyberKnife system to precisely deliver high doses of radiation to tumors with minimal damage to surrounding tissue. The CyberKnife system is robotic and its arm can deliver radiation beams from many angles while continuously tracking and compensating for tumor or patient movement throughout the treatment. CyberKnife treatments typically require just one to five visits and have minimal side effects compared to conventional radiation therapy.
The CyberKnife is a frameless robotic radiosurgery system used to treat both benign and malignant tumors. It was invented in the 1990s and is manufactured by Accuray. It uses a compact linear accelerator mounted on a robotic arm to deliver radiation from many angles and can track tumor motion using X-ray imaging and respiratory tracking sensors. Treatment planning involves defining target volumes and constructing a correspondence model between internal fiducial markers and external sensors to track tumor position in real-time during delivery. The CyberKnife provides an alternative to frame-based radiosurgery and can fractionate treatment over multiple days.
8% of all bone tumors present in spine
25-30% of bone tumors are benign
Peak age: 2-3rd decade
Posterior element involved: osteoid osteoma, osteoblastoma, aneurysmal bone cyst
Anterior element involved: giant cell tumor, hemangioma, eosinophilic granuloma
This document summarizes key points about spinal metastasis including epidemiology, symptoms, diagnostic imaging, and treatment approaches. Spinal metastasis most commonly affects the thoracic spine and presents as back pain in 70-95% of patients. Imaging plays an important role in diagnosis, with MRI and CT being most sensitive and specific. Treatment depends on factors such as neurological involvement, tumor type, and mechanical stability, and may include radiation, surgery, chemotherapy, or bisphosphonates. The goal of treatment is pain relief and preservation of neurological function.
Benign bone tumors are diverse in morphology and biological potential. Most bone tumors are benign lesions seen in patients under 30 years old. Radiology is important for determining the exact location, extent of growth, and aggressiveness of bone tumors. The best test for diagnosis is a biopsy, as it confirms if a tumor is malignant or benign and determines the bone cancer type and stage. There are several classification systems for bone tumors, including the Enneking and Campanacci staging systems, which help determine prognosis and appropriate treatment.
A new software has been developed to measure the hip-knee condylar angle using digital radiological images and computer analysis. In a study comparing the new computerized method to conventional manual goniometry, 60 knee x-rays following total knee arthroplasty were measured twice by the same observer using both methods. Statistical analysis showed the computerized method produced highly reproducible results with a mean difference of 0.324 degrees between readings and a Pearson correlation of 0.999. The new software allows for precise, reliable and inexpensive measurement of joint angles that can be performed by non-medical personnel.
Presacral tumors are rare lesions located in the retrorectal space. They can be congenital, neurogenic, osseous, or other types. MRI is the best imaging modality to evaluate these tumors. Surgical resection is usually required given the risk of malignancy. The surgical approach depends on the location and extent of the tumor, and may involve the abdomen, perineum, or a combined approach. Complete resection with negative margins while preserving function is the goal.
Cyberknife is a robotic radiosurgery system that can treat tumors anywhere in the body with sub-millimeter accuracy. It contains a linear accelerator mounted on a robotic arm that moves in six degrees of freedom to accurately deliver radiation from numerous angles. Treatment is tracked in real-time using x-ray images and the robotic arm moves to correct for any tumor motion during treatment. Cyberknife allows for both single and multiple fraction stereotactic radiosurgery treatments without the need for invasive head frames.
This document discusses sarcomas from a surgical perspective. It defines sarcomas as heterogeneous tumors originating from mesoderm or ectoderm. The most common sarcoma subtypes are pleomorphic sarcoma, gastrointestinal stromal tumor, liposarcoma, and leiomyosarcoma. Sarcomas most often occur in extremities, trunk, and retroperitoneum. Diagnosis involves imaging like MRI or CT along with biopsy. Treatment typically involves surgical resection with negative margins, with chemotherapy or radiation used adjuvantly depending on risk factors. Prognosis depends on factors like size, grade, and margin status.
Ewing sarcoma and osteosarcoma are two of the most common primary bone cancers in children and adolescents. Ewing sarcoma accounts for about 2% of childhood cancers and most often affects bones of the pelvis, femur, and ribs in the second decade of life. The most frequent genetic abnormality in Ewing sarcoma is a translocation between chromosomes 11 and 22. Osteosarcoma is the most common primary bone tumor in children and makes up about 4% of childhood cancers, typically affecting the distal femur, proximal tibia, and proximal humerus. Both cancers commonly present with pain and swelling and can metastasize to the lungs. Treatment involves chemotherapy, surgery, and sometimes radiation.
The Cytotron 864 is a new non-invasive device developed by Scalene Cybernetics for tissue regeneration and repair of chronic diseases like cancer and arthritis. It works by delivering precise doses of radiofrequency beams in the presence of magnetic fields to alter cell membrane potentials and control cell division, thereby stimulating tissue regeneration or stopping tumor growth. The technology was developed by Dr. Rajah Vijay Kumar and his team at the Center for Advanced Research and Development, and clinical studies show it is effective in treating conditions like osteoarthritis and certain types of cancer in a painless manner without side effects.
The parapharyngeal space is a potential space located in the neck that contains important structures like the carotid artery and cranial nerves. Tumors in this space can be benign or malignant, with the most common types being salivary gland tumors in the prestyloid space and neurogenic tumors in the retrostyloid space. Imaging like CT and MRI are used to determine the location and characteristics of the tumor. Surgical excision is typically the primary treatment, with the surgical approach depending on factors like size and involvement of surrounding structures. Observation or radiation therapy may be options for certain patients who cannot undergo surgery.
At our Cancer Care Center in Beloit, Wisconsin we have the most technologically advanced levels of Cancer Surgery. Call our Cancer Care Center at 608-364-5253
Ewing's sarcoma is a rare cancer that affects bones or soft tissue. It is characterized by small, round cancer cells and commonly affects children and young adults. Treatment involves induction chemotherapy, followed by local therapy with surgery or radiation if possible, along with additional maintenance chemotherapy. The multimodal approach has improved survival rates in recent decades, though long-term outcomes remain challenging due to the risk of recurrence or secondary cancers.
The National Comprehensive Cancer Network updated its NCNN Clinical Practice Guidelines in Oncology® to include stereotactic body radiation therapy as a treatment option for prostate cancer. CyberKnife Center of Chicago specializes in stereotactic radiosurgery and stereotactic body radiation therapy using CyberKnife® technology. If you are interested in learning more about CyberKnife Center of Chicago, call 331-221-2050 to speak with a representative.
CyberKnife Center of Chicago presents the American Cancer Society Facts and Figures 2014 annual report outlining the estimated numbers of new cancer cases and deaths in 2014 as well as current cancer incidence, mortality, and survival statistics and information on cancer symptoms, risk factors, early detection and treatment.
A brain tumor is an abnormal growth of cells within the brain or the central spinal canal that can be cancerous or benign. Learn more about brain tumors and how CyberKnife Center of Chicago's noninvasive treatment may work for you
CyberKnife Center of Chicago presents the American Cancer Society Facts and Figures 2013 annual report outlining the estimated numbers of new cancer cases and deaths in 2013 as well as current cancer incidence, mortality, and survival statistics and information on cancer symptoms, risk factors, early detection and treatment.
Lung Cancer is the leading cause of cancer-related deaths in the United States. Learn more about lung tumors and how CyberKnife Center of Chicago's noninvasive treatment may be right for you.
May marks the recognition of National Brain Tumor Awareness Month. Since its establishment in 2008, community organizations and support groups celebrate this month with increased efforts to raise awareness of brain tumors, increase funding for research and educate the public on symptoms and treatment options.
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
1. CyberKnife
Center
of
Chicago
is
a
service
of
Elmhurst
Memorial
Hospital.
200 Berteau Avenue Elmhurst, IL 60126 (331) 221-2050 www.chicagock.com
2. What is CyberKnife?
The
world’s
only
robo/c
radiosurgery
system,
CyberKnife
treats
pa/ents
with
a
procedure
stereotac(c
radiosurgery.
Stereotac/c
radiosurgery
is
a
noninvasive
method
of
trea/ng
tumors
with
high-‐
dose
radia/on
precisely
aimed
from
different
angles.
How
does
CyberKnife
work?
CyberKnife
does
not
require
surgery
and
there
is
no
cu7ng
or
anesthesia
required.
Comprised
of
a
compact
linear
accelerator
-‐
a
machine
that
generates
a
radia/on
beam
-‐
aDached
to
a
highly
maneuverable
robo/c
arm.
• The
machine’s
robo/c
arm
moves
around
you,
aiming
and
firing
targeted
radia/on
beams
from
numerous
angles.
• The
imaging
and
tracking
system
con/nually
updates
the
tumor
loca/on
throughout
the
treatment
procedure,
compensa/ng
for
pa/ent
movements
like
breathing.
• Treatment
sessions
typically
last
30
-‐
90
minutes.
200 Berteau Avenue Elmhurst, IL 60126 (331) 221-2050 www.chicagock.com
4. Why Choose CyberKnife?
CyberKnife
Conven(onal
Linac
Proton
Therapy
Stereotac(c
Radia(on
Stereotac(c
Radiosurgery
Therapy
Radiosurgery
Daily
dose
5.0-‐2.0
1.8-‐3.0
5.0-‐20
1.8-‐2.0
Gy
per
frac/on
Gy
per
frac/on
Gy
per
frac/on
Gy
per
frac/on
Number
of
3-‐5
days
6-‐7
weeks
3-‐5
days
6-‐7
weeks
treatments
Accuracy
((ssue
20-‐30
20-‐30
1.5
millimeters
1-‐5
millimeters
margin)
millimeters
millimeters
Number
of
radia(on
beams
100-‐200+
beams
2-‐7
beams
5-‐15
beams
2-‐3
beams
Con(nuous
correc(on
for
breathing
and
YES
NO
NO
NO
movement
• Treats
pa/ents
in
as
few
as
one
to
five
visits
• Reaches
most
tumors
from
virtually
unlimited
• Pain
free
and
requires
no
anesthesia
direc/ons
with
robo/c
mobility
• Minimal
side
effects
• Minimizes
radia/on
exposure
to
healthy
/ssue
• Outpa/ent
procedure
surrounding
a
tumor
site
• Constantly
corrects
for
tumor
or
pa/ent
movement
• Lesions
previously
treated
with
maximum
allowed
throughout
procedures
radia/on
doses
may
be
treated
200 Berteau Avenue Elmhurst, IL 60126 (331) 221-2050 www.chicagock.com
6. What is the treatment process?
Consulta/on
Meet
with
the
Create
an
individualized
Appointment
CyberKnife
team
treatment
plan
Poten/al
Tissue
Markers
Pretreatment
CT
Scan
MRI
Lab
Studies
(extracranial
tumors
or
lesions)
Procedures*
The
advanced
tracking
CyberKnife’s
system
takes
x-‐ray
CyberKnife
Technicians
help
you
onto
the
robo/c
arm
moves
around
you
firing
images
to
ensure
the
If
needed,
the
pa/ent
returns
for
Treatment
treatment
table
targeted
radia/on
beams
radia/on
beam
remains
locked
on
the
up
to
4
more
treatments.
tumor
Follow-‐up
imaging
and
physical
Follow-‐up
consulta/on
to
monitor
tumor’s
progress
*The
procedures
required
as
part
of
your
individualized
treatment
plan,
and
the
order
in
which
they
will
occur,
will
be
explained
during
your
consulta/on
visit.
200 Berteau Avenue Elmhurst, IL 60126 (331) 221-2050 www.chicagock.com
7. Our Center
CyberKnife
Center
of
Chicago
opened
in
August
2009
and
combines
experienced
physicians
and
the
latest
medical
advances.
At
CyberKnife
Center
of
Chicago,
our
state-‐of-‐the-‐art
technology
offers
hope
to
pa/ents
in
the
Chicago
suburbs
and
beyond.
Two-‐thirds
of
our
pa/ents
have
come
from
outside
Elmhurst
Memorial
Hospital’s
service
area
and
the
center
has
treated
pa/ents
from
as
far
away
as
Montana
and
South
Carolina.
CyberKnife
Center
of
Chicago
has
a
dedicated
CyberKnife
Nurse
Navigator
who
works
with
our
physicians
and
pa/ents
to
coordinate
care
and
manage
the
treatment
process.
Medical
Director:
Dr.
Andy
Su
CyberKnife
Nurse:
Griselle
Romero
Medical
Physicist:
Christopher
Peck
Connect
with
us
200 Berteau Avenue Elmhurst, IL 60126 (331) 221-2050 www.chicagock.com
8. The US Radiosurgery Network
In
partnership
with
Elmhurst
Memorial
Healthcare,
CyberKnife
Center
of
Chicago
is
a
US
Radiosurgery
facility.
Based
in
Nashville,
Tennessee,
US
Radiosurgery
is
a
division
of
Alliance
Oncology
and
partners
with
hospitals
and
physician
groups
around
the
U.S.
to
develop
and
operate
full-‐body
radiosurgical
centers.
Collec(vely,
the
US
Radiosurgery
network
of
centers
has
treated
thousands
of
pa(ents
since
the
opening
of
the
company’s
first
center
in
2003.
The
group
of
facili/es
is
ac/vely
engaged
in
research,
with
physicians
regularly
presen/ng
papers
and
authoring
ar/cles
related
to
the
efficacy
of
CyberKnife
treatment
for
various
types
of
tumors
and
lesions.
Tumors
of
the
lung,
brain
and
prostate,
as
well
as
certain
func/onal
disorders
such
as
trigeminal
neuralgia,
have
become
key
treatment
areas
throughout
the
network
of
centers.
200 Berteau Avenue Elmhurst, IL 60126 (331) 221-2050 www.chicagock.com